Madrigal Pharmaceuticals (MDGL) Net Shares Issued and Repurchased (2012 - 2019)
Analysis
Madrigal Pharmaceuticals (MDGL) Net Shares Issued and Repurchased (2012 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.58 Bn | 130.73 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.33 Bn | 77.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.43 Bn | 58.24 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.84 Bn | 52.70 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.93 Bn | 34.83 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.47 Bn | 32.16 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.39 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 14.93 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 242,500.00 |
| Dec 31, 2018 | 266,400.00 |
| Mar 31, 2018 | 168,900.00 |
| Dec 31, 2017 | 207,700.00 |
| Mar 31, 2017 | 141,000.00 |
| Dec 31, 2016 | 772,410.00 |
| Mar 31, 2016 | 2.79 Mn |
| Dec 31, 2015 | 5.40 Mn |
| Mar 31, 2015 | 1.69 Mn |
| Dec 31, 2014 | 3.28 Mn |
| Mar 31, 2014 | 1.74 Mn |
| Dec 31, 2013 | 1.98 Mn |
| Mar 31, 2013 | 1.70 Mn |
| Dec 31, 2012 | 1.80 Mn |
| Sep 30, 2012 | 1.74 Mn |
| Jun 30, 2012 | 1.31 Mn |